Buy
Back to catalog

Metabolism

Retatrutide

60 mg

Triple agonist (GLP-1, GIP and glucagon) in late-stage clinical research.

  • ≥99% HPLC
  • COA available
  • Quality controlled
Buy at Medxopping Ask a question

Sold exclusively by our official distributor, Medxopping (Brazil).

Retatrutide 60 mg

Research molecule acting on three receptors involved in glucose control and energy expenditure. One of the most closely followed compounds in current metabolic research.

Research areas

  • GLP-1, GIP and glucagon receptor activation
  • Phase 3 clinical trials under way

This product is intended exclusively for research and development. Not for human consumption.

From the same line